- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pembrolizumab/Vibostolimab
Total 2287 results
-
Ruijin HospitalThe First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaboratorsRecruitingEsophageal Squamous Cell CarcinomaChina
-
Andrew Hendifar, MDEOC PharmaActive, not recruitingHepatocellular Carcinoma | Gastric CancerUnited States
-
BrightPath BiotherapeuticsTerminated
-
Arrys TherapeuticsMerck Sharp & Dohme LLCTerminatedNon-small Cell Lung Cancer AdenocarcinomaUnited States
-
ImmunityBio, Inc.Active, not recruitingNon Small Cell Lung CancerUnited States
-
Servier Bio-Innovation LLCMerck Sharp & Dohme LLC; Institut de Recherches Internationales ServierNot yet recruitingMSI-H/dMMR Gastroesophageal-junction Cancer | MSI-H/dMMR Gastric Cancer
-
CNAO National Center of Oncological HadrontherapyFondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Fondazione IRCCS... and other collaboratorsRecruitingMelanoma | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial CarcinomaItaly, Germany
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Institute of Cancer Research, United Kingdom; National...Completed
-
Lytix Biopharma ASLaboratory Corporation of America; OWLActive, not recruitingAdvanced MelanomaUnited States, Spain, France, Norway
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingOral Cavity Carcinoma | Oral Intraepithelial NeoplasiaUnited States
-
Mayo ClinicActive, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Joanne JeterNational Cancer Institute (NCI); Merck Ltd.WithdrawnStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIIA Skin Melanoma
-
Peking Union Medical College HospitalRecruitingBiliary Tract Neoplasms ImmunotherapyChina
-
University of Alabama at BirminghamRecruitingRenal Cell CarcinomaUnited States
-
Samsung Medical CenterRecruitingMetastatic Non-Small Cell Lung CarcinomaKorea, Republic of
-
TiumBio Co., Ltd.Merck Sharp & Dohme LLCRecruitingSolid TumorUnited States
-
NextCure, Inc.Merck Sharp & Dohme LLCRecruitingCervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Endometrial Cancer | Colo-rectal Cancer | Advanced or Metastatic Solid Tumors | Microsatellite Instability Low | Microsatellite Instability High | Microsatellite Stable | Head Neck CancerUnited States
-
Zhejiang Provincial People's HospitalRecruitingHead and Neck Squamous Cell CarcinomaChina
-
Vaccinex Inc.Merck Sharp & Dohme LLCRecruitingRecurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)United States
-
invoX Pharma LimitedMerck Sharp & Dohme LLCRecruitingMetastatic Cancer | Advanced CancerSpain, United States
-
Lyvgen Biopharma Holdings LimitedMerck Sharp & Dohme LLCRecruiting
-
SOTIO Biotech AGSOTIO Biotech a.s.Active, not recruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Mesothelioma | Bladder Cancer | Triple Negative Breast Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Thyroid | Anal Cancer | Merkel Cell Carcinoma | Biliary... and other conditionsUnited States, France, Spain, Czechia
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Merck Sharp & Dohme LLCCompletedUrothelial Bladder CarcinomaItaly
-
Famewave Ltd.TerminatedMelanoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Bladder Cancer | Non-small Cell Lung Carcinoma (NSCLC)United States, Israel
-
Gustave Roussy, Cancer Campus, Grand ParisMerck Sharp & Dohme LLCNot yet recruiting
-
ImmunOs Therapeutics AGMerck Sharp & Dohme LLCRecruiting
-
National University Hospital, SingaporeRecruitingAdenocarcinomas | Recurrent GynecologicalSingapore
-
ARCAGY/ GINECO GROUPMerck Sharp & Dohme LLCRecruitingAddition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT (PembroSCCOHT)Small Cell Ovarian CarcinomaFrance
-
Merck Sharp & Dohme LLCRecruitingCervical Cancer | Small Cell Lung Carcinoma | Neuroendocrine Tumor | Advanced Solid Tumors | Mesothelioma | Vulvar Cancer | Cholangiocarcinoma | Bile Duct Cancer | Endometrial Cancer | Advanced Cancer | Cervical Carcinoma | Endometrial Carcinoma | Thyroid Carcinoma | Thyroid Cancer | Anal Cancer | Colorectal Carcinoma | Carcinoid... and other conditionsCanada, France, Germany, Italy, Mexico, Netherlands, Poland, Russian Federation, Taiwan, United States, Brazil, Colombia, Israel, Korea, Republic of, Norway, Philippines, South Africa, Spain, Australia, Denmark, Chile, Portugal, Peru
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Canada, Italy, Japan, Portugal, Spain, United Kingdom
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingAcute Myeloid Leukemia, in RelapseUnited States
-
Tizona Therapeutics, IncActive, not recruiting
-
Oncorus, Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Cancer | Breast Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Advanced Solid Tumor | Liver Metastases | Colorectal Carcinoma | Non-melanoma Skin CancerUnited States, Canada
-
M.D. Anderson Cancer CenterRecruitingRecurrent Primary Peritoneal High Grade Serous Adenocarcinoma | High Grade Ovarian Serous Adenocarcinoma | Recurrent High Grade Fallopian Tube Serous Adenocarcinoma | Recurrent High Grade Ovarian Serous Adenocarcinoma | High Grade Fallopian Tube Serous Adenocarcinoma | Peritoneal High Grade...United States
-
Fred Hutchinson Cancer CenterMerck Sharp & Dohme LLCCompletedSoft Tissue Sarcoma | Recurrent Soft Tissue SarcomaUnited States
-
Maria Sklodowska-Curie National Research Institute...Biostat Sp. z o.o.RecruitingAdrenocortical CarcinomaPoland
-
University of BirminghamMerck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungUnited Kingdom
-
Istari Oncology, Inc.Active, not recruitingGlioblastoma | Brain Tumor | Recurrent Glioblastoma | Supratentorial GlioblastomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingHodgkin LymphomaAustralia, New Zealand
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnInfiltrating Bladder Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnMetastatic Malignant Solid NeoplasmUnited States
-
Xencor, Inc.RecruitingSolid TumorsUnited States
-
Summit TherapeuticsRecruitingNon-Small Cell Lung CancerUnited States, Canada
-
Asher Biotherapeutics, Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | Renal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and NeckUnited States
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
IO BiotechMerck Sharp & Dohme LLC; Theradex; AlmacRecruitingMelanoma | Squamous Cell Carcinoma of Head and NeckUnited States, Australia, Denmark, Spain, France, Germany
-
ALX Oncology Inc.Merck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Korea, Republic of, United Kingdom, Spain, Belgium, Singapore, Canada, Netherlands, Australia
-
Sumitomo Pharma America, Inc.Syneos HealthTerminated
-
Ikena OncologyGilead SciencesTerminatedRenal Cell Carcinoma | Breast Cancer | Gynecologic Cancer | Colorectal Cancer | Ovarian Cancer | Lung Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Hormone Receptor/Growth Factor Receptor-Negative Breast CancerUnited States